Logo image of GBNH

GREENBROOK TMS INC (GBNH) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:GBNH - CA3937043097 - Common Stock

0.121 USD
-0.08 (-40.69%)
Last: 2/23/2024, 8:00:01 PM
0.1153 USD
-0.01 (-4.71%)
After Hours: 2/23/2024, 8:00:01 PM

GBNH Key Statistics, Chart & Performance

Key Statistics
Market Cap5.18M
Revenue(TTM)80.09M
Net Income(TTM)-68.03M
Shares42.77M
Float13.63M
52 Week High1.82
52 Week Low0.1
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.41
PEN/A
Fwd PEN/A
Earnings (Next)04-15
IPO2018-11-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
GBNH short term performance overview.The bars show the price performance of GBNH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

GBNH long term performance overview.The bars show the price performance of GBNH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GBNH is 0.121 USD. In the past month the price decreased by -59.67%. In the past year, price decreased by -92.98%.

GREENBROOK TMS INC / GBNH Daily stock chart

GBNH Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to GBNH. When comparing the yearly performance of all stocks, GBNH is a bad performer in the overall market: 98.68% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

GBNH Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to GBNH. Both the profitability and financial health of GBNH have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GBNH Financial Highlights

Over the last trailing twelve months GBNH reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -49.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -78.11%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%26.83%
Sales Q2Q%29.13%
EPS 1Y (TTM)-49.69%
Revenue 1Y (TTM)47.06%

GBNH Forecast & Estimates

8 analysts have analysed GBNH and the average price target is 0.66 USD. This implies a price increase of 447.93% is expected in the next year compared to the current price of 0.121.

For the next year, analysts expect an EPS growth of 58.2% and a revenue growth 6.64% for GBNH


Analysts
Analysts80
Price Target0.66 (445.45%)
EPS Next Y58.2%
Revenue Next Year6.64%

GBNH Ownership

Ownership
Inst Owners2.68%
Ins Owners17.86%
Short Float %N/A
Short RatioN/A

About GBNH

Company Profile

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.

Company Info

GREENBROOK TMS INC

890 Yonge St 7th Floor

TORONTO ONTARIO M4W 3P4 CA

CEO: Bill Leonard

Employees: 629

GBNH Company Website

Phone: 14163229700

GREENBROOK TMS INC / GBNH FAQ

What does GREENBROOK TMS INC do?

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.


Can you provide the latest stock price for GREENBROOK TMS INC?

The current stock price of GBNH is 0.121 USD. The price decreased by -40.69% in the last trading session.


Does GBNH stock pay dividends?

GBNH does not pay a dividend.


How is the ChartMill rating for GREENBROOK TMS INC?

GBNH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the sector and industry classification for GREENBROOK TMS INC?

GREENBROOK TMS INC (GBNH) operates in the Health Care sector and the Health Care Providers & Services industry.


Can you provide the market cap for GREENBROOK TMS INC?

GREENBROOK TMS INC (GBNH) has a market capitalization of 5.18M USD. This makes GBNH a Nano Cap stock.


What is the ownership structure of GREENBROOK TMS INC (GBNH)?

You can find the ownership structure of GREENBROOK TMS INC (GBNH) on the Ownership tab.